ArticleLeukemia2021

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML).

Nikhil Patkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.